GSK, Novartis, Sanofi Said To Be Bidding For $500 Million Elder Pharma
This article was originally published in PharmAsia News
GlaxoSmithKline, Novartis and Sanofi are reported to be in various stages of bidding to buy Elder Pharmaceuticals, which could be worth $500 million.
You may also be interested in...
Experts think GLP-1s in neurodegeneration may be Novo Nordisk’s next opportunity and await readouts from the Phase II ELAD trial in Alzheimer's disease for signals.
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.